West Pharmaceutical Services, Inc. (WST)
West Pharmaceutical Services, Inc. Shareholder Equity 2008–2025
West Pharmaceutical Services, Inc. annual shareholder equity history from 2009 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- West Pharmaceutical Services, Inc. shareholder equity as of December 31, 2025: 3.18B, a 18.41% increase year-over-year.
- West Pharmaceutical Services, Inc. shareholder equity for 2025 were 3.18B, a 18.41% increase from 2024.
- West Pharmaceutical Services, Inc. shareholder equity for 2024 were 2.68B, a 6.90% decrease from 2023.
- West Pharmaceutical Services, Inc. shareholder equity for 2023 were 2.88B, a 7.30% increase from 2022.
- West Pharmaceutical Services, Inc. shareholder equity for 2022 were 2.68B.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| West Pharmaceutical Services, Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $3,176 |
| 2024 | $2,682 |
| 2023 | $2,881 |
| 2022 | $2,685 |
| 2021 | $2,335 |
| 2020 | $1,855 |
| 2019 | $1,573 |
| 2018 | $1,396 |
| 2017 | $1,280 |
| 2016 | $1,118 |
| 2015 | $1,024 |
| 2014 | $957 |
| 2013 | $906 |
| 2012 | $729 |
| 2011 | $655 |
West Pharmaceutical Services, Inc. Shareholder Equity — FAQ
West Pharmaceutical Services, Inc. (WST) shareholder equity over the last 18 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see WST's shareholder equity history?
The chart and table above show West Pharmaceutical Services, Inc.'s shareholder equity by year and by quarter, including the growth rate.